Q&A with Dilip G Shah Gireesh Babu | Chennai October 8, 2015 Last Updated at 11:08 IST The Indian Pharmaceutical Alliance (IPA) represents the top... ...http://www.business-standard.com/article/companies/we-want-an-efficient-transparent-and-predictable-regime-ipa-general-secretary-115100800181_1.html
Delhi HC bars Glenmark from selling, distributing, marketing or exporting its anti-diabetes drugs Zita and Zita-Met Priyanka MittalReghu... ...http://www.livemint.com/Companies/PGkIqX2I7gGhNeHeyFNzKL/Glenmark-restrained-from-selling-antidiabetes-drug-by-Delhi.html
Indian drugmakers urged the government not to give in to mounting pressure from a section of US senators for tighter intellectual property (IP)... ...http://www.medindia.net/news/indian-pharma-companies-urge-government-to-fend-off-us-demand-153875-1.htm
A new drug pricing regime came into force in 2013, covering about 680 formulations of specified strengths across 27 therapeutic categories.... ...http://www.financialexpress.com/article/industry/companies/price-regulator-acts-tough-firms-hit-by-impasse-in-new-drug-approvals/138759/
Several American pharma industry players have raised concerns over India’s patent act particularly Section 3(d), which restricts patents for... ...http://www.rediff.com/money/report/govt-readies-improved-ipr-policy-before-pm-modis-us-visit/20150913.htm
Niche Pharmaceuticals Nourishes...